Osteosarcoma (OS) is type of bone tumour that mostly affects children and young adults. Survival rates have improved little over the past four decades and it is still poorly understood how the disease develops and spreads. Dr Sam Behjati and his team will analyse the gene activity of growing and spreading OS cells to identify key targets for the development of effective new treatments and more accurate monitoring techniques.
Developmental states of localised and metastatic osteosarcoma cells – a knowledge bank for novel biomarkers and therapeutic approaches
Dr Sam Behjati
Wellcome Sanger Institute
Cambridge, CB10 1SA
14 December 2020